Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 79Leukemia, Myeloid, Acute 69Leukemia 57Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Myeloproliferative Disorders 38Leukemia, Myeloid, Accelerated Phase 36Leukemia, Myelomonocytic, Chronic 35Leukemia, Myeloid, Chronic-Phase 35Leukemia, Lymphocytic, Chronic, B-Cell 32Hodgkin Disease 32Congenital Abnormalities 32Blast Crisis 31Multiple Myeloma 30Lymphoma, Non-Hodgkin 29Graft vs Host Disease 29Lymphoma 28Primary Myelofibrosis 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Follicular 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Myelodysplastic-Myeloproliferative Diseases 23Lymphoma, Mantle-Cell 23Lymphoma, Large-Cell, Immunoblastic 23Burkitt Lymphoma 23Anemia, Refractory, with Excess of Blasts 23Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 21Neoplasms, Plasma Cell 20Recurrence 15Leukemia, Myelomonocytic, Juvenile 15

Interventions

Peripheral Blood Stem Cell Transplantation 8fludarabine phosphate 7Mycophenolic Acid 6Whole-Body Irradiation 5Cyclosporine 5Cyclophosphamide 5Tacrolimus 3Filgrastim 3liposomal amphotericin B 2Radiotherapy 2Morphine 2Methylprednisolone 2Interferon-alpha 2Fentanyl 2Early Intervention, Educational 2Caspofungin 2Carboplatin 2Busulfan 2Antilymphocyte Serum 2sargramostim 1pyroxamide 1nelarabine 1ethanolamine oleate 1aldesleukin 1Watchful Waiting 1Valganciclovir 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Topotecan 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoglobulin Light-chain Amyloidosis × Methotrexate × Myeloid × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡